Neurology: People, Pipelines, Progress
Neurology Nexus: Why 2025 is a Defining Year for Brain Science
The Neurology: People, Pipelines, Progress ARTO Report reveals a major inflection point in the neurology market, with projections showing it will grow from $67.3B in 2024 to $94.8B by 2029 (a 7.1% CAGR). This optimism is driven by landmark drug approvals, transformative AI applications, and the emergence of breakthrough therapies for previously untreatable conditions like Alzheimer’s and Parkinson’s. However, talent shortages, particularly in neurologists and CNS specialists, pose a critical constraint.
What you’ll learn in this report:
- Talent Shortages and Skills Gaps in Neurology
Discover why only 1 in 4 neurologist roles is filled in some regions, and how companies are responding with academic partnerships, global recruitment, and talent pipeline initiatives.
- AI’s Expanding Role in Neurological Diagnosis and Treatment
From stroke detection to clinical decision support, learn how AI is revolutionising patient care, diagnostics, and drug discovery in the neurology space.
- The Rise of Transformative Treatments
Explore the next wave of therapies—from gene editing and cell regeneration to fast-acting psychedelics—targeting diseases like Huntington’s, epilepsy, and depression.
- Key Drug Launches to Watch in 2025
Get a preview of high-impact FDA approvals set to reshape the market, including Donanemab, KarXT, and AXS-05,collectively projected to generate over $29B in annual sales.
- Highlights from the 2025 AAN Conference
Review five standout clinical studies from the world’s largest neurology meeting, offering insights into next-gen therapies for conditions ranging from spinal cord injury to rare paediatric diseases.
Read the full report to stay ahead of the curve.
